The forecast for nervous system medicine sales in Japan from 2024 to 2028 shows a steady increase from 1.018 trillion to 1.0733 trillion Japanese Yen, indicating a consistent annual growth trend. As of 2023, sales were below 1.018 trillion Yen, marking continuous growth. Year-on-year growth ranges from approximately 1.37% to 1.28%, highlighting a gradually decelerating trend. Over the five-year period, the compound annual growth rate (CAGR) is estimated around 1.33%.

Future trends to watch for include:

Demographic shifts, such as an aging population, impacting medication demand.
Innovations in treatment methods and medication formulations.
Economic factors and healthcare policies influencing market conditions and accessibility.